AXCELIS TECHNOLOGIES INC (ACLS) Fundamental Analysis & Valuation

NASDAQ:ACLS • US0545402085

Current stock price

85.74 USD
+0.59 (+0.69%)
At close:
84 USD
-1.74 (-2.03%)
Pre-Market:

This ACLS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. ACLS Profitability Analysis

1.1 Basic Checks

  • In the past year ACLS was profitable.
  • In the past year ACLS had a positive cash flow from operations.
  • Each year in the past 5 years ACLS has been profitable.
  • In the past 5 years ACLS always reported a positive cash flow from operatings.
ACLS Yearly Net Income VS EBIT VS OCF VS FCFACLS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M 200M 250M

1.2 Ratios

  • The Return On Assets of ACLS (8.83%) is better than 79.13% of its industry peers.
  • Looking at the Return On Equity, with a value of 11.62%, ACLS is in the better half of the industry, outperforming 75.65% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 8.93%, ACLS is in the better half of the industry, outperforming 79.13% of the companies in the same industry.
  • ACLS had an Average Return On Invested Capital over the past 3 years of 16.09%. This is significantly above the industry average of 10.52%.
  • The last Return On Invested Capital (8.93%) for ACLS is well below the 3 year average (16.09%), which needs to be investigated, but indicates that ACLS had better years and this may not be a problem.
Industry RankSector Rank
ROA 8.83%
ROE 11.62%
ROIC 8.93%
ROA(3y)14.31%
ROA(5y)14.82%
ROE(3y)19.98%
ROE(5y)21.14%
ROIC(3y)16.09%
ROIC(5y)18.16%
ACLS Yearly ROA, ROE, ROICACLS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • Looking at the Profit Margin, with a value of 14.33%, ACLS is in the better half of the industry, outperforming 73.91% of the companies in the same industry.
  • ACLS's Profit Margin has improved in the last couple of years.
  • The Operating Margin of ACLS (14.22%) is better than 71.30% of its industry peers.
  • ACLS's Operating Margin has improved in the last couple of years.
  • ACLS's Gross Margin of 44.91% is in line compared to the rest of the industry. ACLS outperforms 52.17% of its industry peers.
  • ACLS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 14.22%
PM (TTM) 14.33%
GM 44.91%
OM growth 3Y-14.92%
OM growth 5Y3.08%
PM growth 3Y-10.37%
PM growth 5Y6.35%
GM growth 3Y0.94%
GM growth 5Y1.43%
ACLS Yearly Profit, Operating, Gross MarginsACLS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. ACLS Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ACLS is creating some value.
  • Compared to 1 year ago, ACLS has less shares outstanding
  • ACLS has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for ACLS has been reduced compared to a year ago.
ACLS Yearly Shares OutstandingACLS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
ACLS Yearly Total Debt VS Total AssetsACLS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • ACLS has an Altman-Z score of 6.92. This indicates that ACLS is financially healthy and has little risk of bankruptcy at the moment.
  • ACLS has a Altman-Z score of 6.92. This is in the better half of the industry: ACLS outperforms 62.61% of its industry peers.
  • ACLS has a debt to FCF ratio of 0.40. This is a very positive value and a sign of high solvency as it would only need 0.40 years to pay back of all of its debts.
  • ACLS's Debt to FCF ratio of 0.40 is amongst the best of the industry. ACLS outperforms 81.74% of its industry peers.
  • ACLS has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
  • ACLS's Debt to Equity ratio of 0.04 is fine compared to the rest of the industry. ACLS outperforms 61.74% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.4
Altman-Z 6.92
ROIC/WACC0.78
WACC11.39%
ACLS Yearly LT Debt VS Equity VS FCFACLS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • ACLS has a Current Ratio of 4.77. This indicates that ACLS is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 4.77, ACLS is in the better half of the industry, outperforming 72.17% of the companies in the same industry.
  • ACLS has a Quick Ratio of 3.11. This indicates that ACLS is financially healthy and has no problem in meeting its short term obligations.
  • ACLS's Quick ratio of 3.11 is fine compared to the rest of the industry. ACLS outperforms 63.48% of its industry peers.
Industry RankSector Rank
Current Ratio 4.77
Quick Ratio 3.11
ACLS Yearly Current Assets VS Current LiabilitesACLS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. ACLS Growth Analysis

3.1 Past

  • The earnings per share for ACLS have decreased strongly by -20.81% in the last year.
  • Measured over the past years, ACLS shows a very strong growth in Earnings Per Share. The EPS has been growing by 29.06% on average per year.
  • The Revenue for ACLS has decreased by -17.57% in the past year. This is quite bad
  • ACLS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.07% yearly.
EPS 1Y (TTM)-20.81%
EPS 3Y-3.74%
EPS 5Y29.06%
EPS Q2Q%-3.25%
Revenue 1Y (TTM)-17.57%
Revenue growth 3Y-3.02%
Revenue growth 5Y12.07%
Sales Q2Q%-5.58%

3.2 Future

  • The Earnings Per Share is expected to decrease by -2.80% on average over the next years.
  • ACLS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.32% yearly.
EPS Next Y-23.59%
EPS Next 2Y-2.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.78%
Revenue Next 2Y5.32%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ACLS Yearly Revenue VS EstimatesACLS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
ACLS Yearly EPS VS EstimatesACLS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

5

4. ACLS Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 17.61, which indicates a rather expensive current valuation of ACLS.
  • 90.43% of the companies in the same industry are more expensive than ACLS, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of ACLS to the average of the S&P500 Index (25.79), we can say ACLS is valued slightly cheaper.
  • A Price/Forward Earnings ratio of 23.04 indicates a rather expensive valuation of ACLS.
  • 77.39% of the companies in the same industry are more expensive than ACLS, based on the Price/Forward Earnings ratio.
  • ACLS is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.80, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 17.61
Fwd PE 23.04
ACLS Price Earnings VS Forward Price EarningsACLS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • ACLS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ACLS is cheaper than 85.22% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, ACLS is valued cheaper than 87.83% of the companies in the same industry.
Industry RankSector Rank
P/FCF 24.61
EV/EBITDA 15.14
ACLS Per share dataACLS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • ACLS has an outstanding profitability rating, which may justify a higher PE ratio.
  • A cheap valuation may be justified as ACLS's earnings are expected to decrease with -2.80% in the coming years.
PEG (NY)N/A
PEG (5Y)0.61
EPS Next 2Y-2.8%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ACLS Dividend Analysis

5.1 Amount

  • No dividends for ACLS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ACLS Fundamentals: All Metrics, Ratios and Statistics

AXCELIS TECHNOLOGIES INC

NASDAQ:ACLS (3/18/2026, 8:00:00 PM)

Premarket: 84 -1.74 (-2.03%)

85.74

+0.59 (+0.69%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-17
Earnings (Next)05-04
Inst Owners107.81%
Inst Owner Change3.38%
Ins Owners0.57%
Ins Owner Change-1.07%
Market Cap2.63B
Revenue(TTM)839.05M
Net Income(TTM)120.24M
Analysts50.91
Price Target107.25 (25.09%)
Short Float %12.11%
Short Ratio4.56
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.43%
Min EPS beat(2)18.27%
Max EPS beat(2)30.58%
EPS beat(4)4
Avg EPS beat(4)66.14%
Min EPS beat(4)18.27%
Max EPS beat(4)163.95%
EPS beat(8)8
Avg EPS beat(8)40.33%
EPS beat(12)12
Avg EPS beat(12)31.33%
EPS beat(16)16
Avg EPS beat(16)28.84%
Revenue beat(2)2
Avg Revenue beat(2)6.67%
Min Revenue beat(2)4.69%
Max Revenue beat(2)8.66%
Revenue beat(4)4
Avg Revenue beat(4)4.62%
Min Revenue beat(4)2.12%
Max Revenue beat(4)8.66%
Revenue beat(8)7
Avg Revenue beat(8)2.58%
Revenue beat(12)11
Avg Revenue beat(12)2.76%
Revenue beat(16)15
Avg Revenue beat(16)2.72%
PT rev (1m)-2.39%
PT rev (3m)0.36%
EPS NQ rev (1m)-31.58%
EPS NQ rev (3m)-32.49%
EPS NY rev (1m)-18.93%
EPS NY rev (3m)-19.69%
Revenue NQ rev (1m)-6.96%
Revenue NQ rev (3m)-7.29%
Revenue NY rev (1m)-3.8%
Revenue NY rev (3m)-3.86%
Valuation
Industry RankSector Rank
PE 17.61
Fwd PE 23.04
P/S 3.14
P/FCF 24.61
P/OCF 22.26
P/B 2.55
P/tB 2.55
EV/EBITDA 15.14
EPS(TTM)4.87
EY5.68%
EPS(NY)3.72
Fwd EY4.34%
FCF(TTM)3.48
FCFY4.06%
OCF(TTM)3.85
OCFY4.49%
SpS27.31
BVpS33.68
TBVpS33.68
PEG (NY)N/A
PEG (5Y)0.61
Graham Number60.75
Profitability
Industry RankSector Rank
ROA 8.83%
ROE 11.62%
ROCE 10.25%
ROIC 8.93%
ROICexc 13.17%
ROICexgc 13.17%
OM 14.22%
PM (TTM) 14.33%
GM 44.91%
FCFM 12.75%
ROA(3y)14.31%
ROA(5y)14.82%
ROE(3y)19.98%
ROE(5y)21.14%
ROIC(3y)16.09%
ROIC(5y)18.16%
ROICexc(3y)30.86%
ROICexc(5y)36.82%
ROICexgc(3y)30.86%
ROICexgc(5y)36.82%
ROCE(3y)18.46%
ROCE(5y)20.85%
ROICexgc growth 3Y-38.1%
ROICexgc growth 5Y-2.58%
ROICexc growth 3Y-38.1%
ROICexc growth 5Y-2.58%
OM growth 3Y-14.92%
OM growth 5Y3.08%
PM growth 3Y-10.37%
PM growth 5Y6.35%
GM growth 3Y0.94%
GM growth 5Y1.43%
F-Score5
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.4
Debt/EBITDA 0.3
Cap/Depr 64.13%
Cap/Sales 1.35%
Interest Coverage 250
Cash Conversion 86.4%
Profit Quality 89%
Current Ratio 4.77
Quick Ratio 3.11
Altman-Z 6.92
F-Score5
WACC11.39%
ROIC/WACC0.78
Cap/Depr(3y)99.74%
Cap/Depr(5y)94.41%
Cap/Sales(3y)1.46%
Cap/Sales(5y)1.37%
Profit Quality(3y)69.44%
Profit Quality(5y)92.72%
High Growth Momentum
Growth
EPS 1Y (TTM)-20.81%
EPS 3Y-3.74%
EPS 5Y29.06%
EPS Q2Q%-3.25%
EPS Next Y-23.59%
EPS Next 2Y-2.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-17.57%
Revenue growth 3Y-3.02%
Revenue growth 5Y12.07%
Sales Q2Q%-5.58%
Revenue Next Year2.78%
Revenue Next 2Y5.32%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-43.57%
EBIT growth 3Y-17.49%
EBIT growth 5Y15.52%
EBIT Next Year-9.22%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-16.81%
FCF growth 3Y-19.47%
FCF growth 5Y11.43%
OCF growth 1Y-15.99%
OCF growth 3Y-18.13%
OCF growth 5Y11.16%

AXCELIS TECHNOLOGIES INC / ACLS Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for AXCELIS TECHNOLOGIES INC?

ChartMill assigns a fundamental rating of 6 / 10 to ACLS.


Can you provide the valuation status for AXCELIS TECHNOLOGIES INC?

ChartMill assigns a valuation rating of 5 / 10 to AXCELIS TECHNOLOGIES INC (ACLS). This can be considered as Fairly Valued.


What is the profitability of ACLS stock?

AXCELIS TECHNOLOGIES INC (ACLS) has a profitability rating of 8 / 10.


What is the valuation of AXCELIS TECHNOLOGIES INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for AXCELIS TECHNOLOGIES INC (ACLS) is 17.61 and the Price/Book (PB) ratio is 2.55.


What is the earnings growth outlook for AXCELIS TECHNOLOGIES INC?

The Earnings per Share (EPS) of AXCELIS TECHNOLOGIES INC (ACLS) is expected to decline by -23.59% in the next year.